| Symbol |
Name |
|
ACE
|
angiotensin I converting enzyme
|
|
ADAMTS13
|
ADAM metallopeptidase with thrombospondin type 1 motif, 13
|
|
ADRA2B
|
adrenoceptor alpha 2B
|
|
AGER
|
advanced glycosylation end product-specific receptor
|
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
|
|
AGTR1
|
angiotensin II receptor, type 1
|
|
AGTR2
|
angiotensin II receptor, type 2
|
|
AHR
|
aryl hydrocarbon receptor
|
|
ALB
|
albumin
|
|
ALOX5
|
arachidonate 5-lipoxygenase
|
|
ANGPT2
|
angiopoietin 2
|
|
ANXA2
|
annexin A2
|
|
ANXA5
|
annexin A5
|
|
APOA5
|
apolipoprotein A-V
|
|
APOE
|
apolipoprotein E
|
|
ARG2
|
arginase 2
|
|
ARHGEF2
|
Rho/Rac guanine nucleotide exchange factor (GEF) 2
|
|
BCAR1
|
breast cancer anti-estrogen resistance 1
|
|
BGN
|
biglycan
|
|
BIRC3
|
baculoviral IAP repeat containing 3
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BMP2
|
bone morphogenetic protein 2
|
|
BMP4
|
bone morphogenetic protein 4
|
|
BMX
|
BMX non-receptor tyrosine kinase
|
|
BSG
|
basigin (Ok blood group)
|
|
C5
|
complement component 5
|
|
CALR
|
calreticulin
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CAT
|
catalase
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCL22
|
chemokine (C-C motif) ligand 22
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CD68
|
CD68 molecule
|
|
CD74
|
CD74 molecule, major histocompatibility complex, class II invariant chain
|
|
CDH5
|
cadherin 5, type 2 (vascular endothelium)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CFH
|
complement factor H
|
|
CHKA
|
choline kinase alpha
|
|
CITED2
|
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2
|
|
CLCN3
|
chloride channel, voltage-sensitive 3
|
|
CLDN5
|
claudin 5
|
|
CNR2
|
cannabinoid receptor 2 (macrophage)
|
|
COL3A1
|
collagen, type III, alpha 1
|
|
CREB1
|
cAMP responsive element binding protein 1
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CTGF
|
connective tissue growth factor
|
|
CTSL
|
cathepsin L
|
|
CXADR
|
coxsackie virus and adenovirus receptor
|
|
CXCL1
|
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha)
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL3
|
chemokine (C-X-C motif) ligand 3
|
|
CXCL5
|
chemokine (C-X-C motif) ligand 5
|
|
CXCL6
|
chemokine (C-X-C motif) ligand 6
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CXORF40A
|
chromosome X open reading frame 40A
|
|
CYBB
|
cytochrome b-245, beta polypeptide
|
|
CYP2C9
|
cytochrome P450, family 2, subfamily C, polypeptide 9
|
|
CYP4V2
|
cytochrome P450, family 4, subfamily V, polypeptide 2
|
|
CYR61
|
cysteine-rich, angiogenic inducer, 61
|
|
DCN
|
decorin
|
|
DEFB4A
|
defensin, beta 4A
|
|
ECE1
|
endothelin converting enzyme 1
|
|
EDN1
|
endothelin 1
|
|
EDNRA
|
endothelin receptor type A
|
|
EDNRB
|
endothelin receptor type B
|
|
EFNB2
|
ephrin-B2
|
|
EGFL7
|
EGF-like-domain, multiple 7
|
|
EPAS1
|
endothelial PAS domain protein 1
|
|
EPCAM
|
epithelial cell adhesion molecule
|
|
EPHA2
|
EPH receptor A2
|
|
EPHB4
|
EPH receptor B4
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
EZH2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
|
F10
|
coagulation factor X
|
|
F11
|
coagulation factor XI
|
|
F12
|
coagulation factor XII (Hageman factor)
|
|
F2
|
coagulation factor II (thrombin)
|
|
F2R
|
coagulation factor II (thrombin) receptor
|
|
F2RL1
|
coagulation factor II (thrombin) receptor-like 1
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
|
F5
|
coagulation factor V (proaccelerin, labile factor)
|
|
F7
|
coagulation factor VII (serum prothrombin conversion accelerator)
|
|
F8
|
coagulation factor VIII, procoagulant component
|
|
F9
|
coagulation factor IX
|
|
FAS
|
Fas cell surface death receptor
|
|
FGA
|
fibrinogen alpha chain
|
|
FGF1
|
fibroblast growth factor 1 (acidic)
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
|
FGG
|
fibrinogen gamma chain
|
|
FHL5
|
four and a half LIM domains 5
|
|
FIGF
|
c-fos induced growth factor (vascular endothelial growth factor D)
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
FN1
|
fibronectin 1
|
|
FOS
|
FBJ murine osteosarcoma viral oncogene homolog
|
|
FOXC2
|
forkhead box C2
|
|
FOXO3
|
forkhead box O3
|
|
GATA6
|
GATA binding protein 6
|
|
GCK
|
glucokinase (hexokinase 4)
|
|
GDF15
|
growth differentiation factor 15
|
|
GJA1
|
gap junction protein, alpha 1, 43kDa
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GSTK1
|
glutathione S-transferase kappa 1
|
|
HAMP
|
hepcidin antimicrobial peptide
|
|
HEPH
|
hephaestin
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HMGB1
|
high mobility group box 1
|
|
HMGCR
|
3-hydroxy-3-methylglutaryl-CoA reductase
|
|
HMOX1
|
heme oxygenase 1
|
|
HSD11B1
|
hydroxysteroid (11-beta) dehydrogenase 1
|
|
HSPG2
|
heparan sulfate proteoglycan 2
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
IFNB1
|
interferon, beta 1, fibroblast
|
|
IFNL3
|
interferon, lambda 3
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGFBP3
|
insulin-like growth factor binding protein 3
|
|
IL10
|
interleukin 10
|
|
IL18
|
interleukin 18
|
|
IL6
|
interleukin 6
|
|
INHA
|
inhibin, alpha
|
|
INHBA
|
inhibin, beta A
|
|
INHBB
|
inhibin, beta B
|
|
INS
|
insulin
|
|
ITGA2
|
integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor)
|
|
ITGA4
|
integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor)
|
|
ITGA5
|
integrin, alpha 5 (fibronectin receptor, alpha polypeptide)
|
|
ITGAV
|
integrin, alpha V
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)
|
|
ITGB3
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
|
|
ITGB4
|
integrin, beta 4
|
|
ITGB5
|
integrin, beta 5
|
|
JAK2
|
Janus kinase 2
|
|
JUN
|
jun proto-oncogene
|
|
KDR
|
kinase insert domain receptor
|
|
KISS1
|
KiSS-1 metastasis-suppressor
|
|
KLF2
|
Kruppel-like factor 2
|
|
KRT8
|
keratin 8, type II
|
|
LEP
|
leptin
|
|
LOXL1
|
lysyl oxidase-like 1
|
|
LPA
|
lipoprotein, Lp(a)
|
|
LTBR
|
lymphotoxin beta receptor (TNFR superfamily, member 3)
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MAPKAPK3
|
mitogen-activated protein kinase-activated protein kinase 3
|
|
MIR143
|
microRNA 143
|
|
MIR145
|
microRNA 145
|
|
MIR146A
|
microRNA 146a
|
|
MIR155
|
microRNA 155
|
|
MIR17
|
microRNA 17
|
|
MIR19A
|
microRNA 19a
|
|
MIR19B1
|
microRNA 19b-1
|
|
MIR214
|
microRNA 214
|
|
MIR299
|
microRNA 299
|
|
MIR29A
|
microRNA 29a
|
|
MIR34A
|
microRNA 34a
|
|
MIR361
|
microRNA 361
|
|
MIRLET7C
|
microRNA let-7c
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP3
|
matrix metallopeptidase 3
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MTRR
|
5-methyltetrahydrofolate-homocysteine methyltransferase reductase
|
|
MX1
|
MX dynamin-like GTPase 1
|
|
MXRA8
|
matrix-remodelling associated 8
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
NAMPT
|
nicotinamide phosphoribosyltransferase
|
|
NDRG1
|
N-myc downstream regulated 1
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NMS
|
neuromedin S
|
|
NOS1
|
nitric oxide synthase 1 (neuronal)
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NOTCH4
|
notch 4
|
|
NOX4
|
NADPH oxidase 4
|
|
NPPA
|
natriuretic peptide A
|
|
NR2F2
|
nuclear receptor subfamily 2, group F, member 2
|
|
OSM
|
oncostatin M
|
|
P2RY12
|
purinergic receptor P2Y, G-protein coupled, 12
|
|
P4HB
|
prolyl 4-hydroxylase, beta polypeptide
|
|
PAK1
|
p21 protein (Cdc42/Rac)-activated kinase 1
|
|
PDCD1
|
programmed cell death 1
|
|
PECAM1
|
platelet/endothelial cell adhesion molecule 1
|
|
PF4
|
platelet factor 4
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
|
PLAT
|
plasminogen activator, tissue
|
|
PLAU
|
plasminogen activator, urokinase
|
|
PLAUR
|
plasminogen activator, urokinase receptor
|
|
PLCG1
|
phospholipase C, gamma 1
|
|
PLG
|
plasminogen
|
|
PON1
|
paraoxonase 1
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPIA
|
peptidylprolyl isomerase A (cyclophilin A)
|
|
PPP1R12A
|
protein phosphatase 1, regulatory subunit 12A
|
|
PRCP
|
prolylcarboxypeptidase (angiotensinase C)
|
|
PRKCD
|
protein kinase C, delta
|
|
PRKCZ
|
protein kinase C, zeta
|
|
PROC
|
protein C (inactivator of coagulation factors Va and VIIIa)
|
|
PROCR
|
protein C receptor, endothelial
|
|
PROK1
|
prokineticin 1
|
|
PROS1
|
protein S (alpha)
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGER1
|
prostaglandin E receptor 1 (subtype EP1), 42kDa
|
|
PTGER4
|
prostaglandin E receptor 4 (subtype EP4)
|
|
PTGFR
|
prostaglandin F receptor (FP)
|
|
PTGIR
|
prostaglandin I2 (prostacyclin) receptor (IP)
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTK2
|
protein tyrosine kinase 2
|
|
PTK2B
|
protein tyrosine kinase 2 beta
|
|
PXN
|
paxillin
|
|
RAC1
|
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
|
|
RAP1A
|
RAP1A, member of RAS oncogene family
|
|
RAPGEF3
|
Rap guanine nucleotide exchange factor (GEF) 3
|
|
RBP4
|
retinol binding protein 4, plasma
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
REN
|
renin
|
|
RHOA
|
ras homolog family member A
|
|
RORA
|
RAR-related orphan receptor A
|
|
S100A13
|
S100 calcium binding protein A13
|
|
S1PR1
|
sphingosine-1-phosphate receptor 1
|
|
SELE
|
selectin E
|
|
SEPT11
|
septin 11
|
|
SERPINB2
|
serpin peptidase inhibitor, clade B (ovalbumin), member 2
|
|
SERPINC1
|
serpin peptidase inhibitor, clade C (antithrombin), member 1
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SERPINF1
|
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1
|
|
SERPING1
|
serpin peptidase inhibitor, clade G (C1 inhibitor), member 1
|
|
SGK1
|
serum/glucocorticoid regulated kinase 1
|
|
SH2B3
|
SH2B adaptor protein 3
|
|
SIRT1
|
sirtuin 1
|
|
SLC29A2
|
solute carrier family 29 (equilibrative nucleoside transporter), member 2
|
|
SMAD6
|
SMAD family member 6
|
|
SOCS3
|
suppressor of cytokine signaling 3
|
|
SP1
|
Sp1 transcription factor
|
|
SPP1
|
secreted phosphoprotein 1
|
|
SST
|
somatostatin
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
SUSD6
|
sushi domain containing 6
|
|
SYNM
|
synemin, intermediate filament protein
|
|
TERT
|
telomerase reverse transcriptase
|
|
TET2
|
tet methylcytosine dioxygenase 2
|
|
TFPI
|
tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor)
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGM1
|
transglutaminase 1
|
|
TGM2
|
transglutaminase 2
|
|
THBD
|
thrombomodulin
|
|
THBS1
|
thrombospondin 1
|
|
THY1
|
Thy-1 cell surface antigen
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
|
TIMP2
|
TIMP metallopeptidase inhibitor 2
|
|
TIMP3
|
TIMP metallopeptidase inhibitor 3
|
|
TLR4
|
toll-like receptor 4
|
|
TNF
|
tumor necrosis factor
|
|
TNFAIP3
|
tumor necrosis factor, alpha-induced protein 3
|
|
TNFRSF10A
|
tumor necrosis factor receptor superfamily, member 10a
|
|
TNFRSF10B
|
tumor necrosis factor receptor superfamily, member 10b
|
|
TNFRSF11B
|
tumor necrosis factor receptor superfamily, member 11b
|
|
TNFRSF12A
|
tumor necrosis factor receptor superfamily, member 12A
|
|
TNFRSF14
|
tumor necrosis factor receptor superfamily, member 14
|
|
TNFSF11
|
tumor necrosis factor (ligand) superfamily, member 11
|
|
TNFSF12
|
tumor necrosis factor (ligand) superfamily, member 12
|
|
TNFSF14
|
tumor necrosis factor (ligand) superfamily, member 14
|
|
TNNT2
|
troponin T type 2 (cardiac)
|
|
TP53
|
tumor protein p53
|
|
TYMP
|
thymidine phosphorylase
|
|
UBE2C
|
ubiquitin-conjugating enzyme E2C
|
|
UCN
|
urocortin
|
|
UTS2
|
urotensin 2
|
|
VASH1
|
vasohibin 1
|
|
VCAM1
|
vascular cell adhesion molecule 1
|
|
VCAN
|
versican
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VKORC1
|
vitamin K epoxide reductase complex, subunit 1
|
|
VTN
|
vitronectin
|
|
VWF
|
von Willebrand factor
|
|
WISP1
|
WNT1 inducible signaling pathway protein 1
|
|
XBP1
|
X-box binding protein 1
|
|
ZYX
|
zyxin
|
